Anthropic warns of ‘existential risks to humanity’ from AI; AstraZeneca makes $2bn cancer drug tie-up – business live
Rolling coverage of the latest economic and financial news The Financial Times have also scrutinised Anthropic’s IPO prospectus, and report that the Claude maker also provided investors with a clearer picture of the challenging economics of building state of the art AI models. The FT says : Anthropic said it plans to spend $518bn on cloud, computing and infrastructure obligations in the coming…
Anthropic, the creator of the AI language model Claude, has issued a warning about the potential "existential risks to humanity" posed by artificial intelligence. The company's IPO prospectus, analyzed by The Financial Times, revealed that Anthropic anticipates substantial expenditures on cloud, computing, and infrastructure to sustain its rapid growth.
Investors are optimistic, anticipating a valuation exceeding $2tn for the company, which would more than double its last funding round valuation and surpass the $1.78tn achieved by Elon Musk's SpaceX. Anthropic's strategic focus includes expanding its oncology portfolio through bispecific therapies targeting PD-1 and VEGF, potentially improving upon existing immunotherapies, particularly in lung, breast, and gastrointestinal cancers.
Written by urgent.news from Guardian Technology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- 'AI could endanger humanity': Anthropic warns economictimes.indiatimes.com
- Anthropic to warn investors of AI's 'risks to humanity' rte.ie
- OpenAI scraps GPT-6.1 Astra release over safety, Anthropic warns of AI risks in IPO filing indianexpress.com
- Anthropic warns of ‘existential risks to humanity’ from AI; AstraZeneca makes $2bn cancer drug tie-up – business live theguardian.com
